The FY20 Defense Appropriations Act provides funding to the Department of Defense Pancreatic Cancer Research Program to support a collaborative pancreatic cancer research paradigm that reduces the burden of pancreatic cancer.
The FY20 Defense Appropriations Act provides funding to the Department of Defense Rare Cancers Research Program to support for research of exceptional scientific merit in the area of rare cancers research. The RCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY20... […]
Marc Theoret, Julia Beaver, Tamy Kim and Laleh Amiri-Kordestani were named to new positions at FDA.
Markus Müschen was named the inaugural director of the Center of Molecular and Cellular Oncology at Yale Cancer Center and Smilow Cancer Hospital. Müschen will also be appointed Arthur H. and Isabel Bunker Professor of Medicine (hematology) and professor of immunobiology at Yale School of Medicine.
Debra Friedman, E. Bronson Ingram Chair of Pediatric Oncology, was named associate director of community science and health outcomes at Vanderbilt-Ingram Cancer Center.
Janice M. Mehnert, an expert in phase I therapeutics and the treatment of skin malignancies, was named associate director for clinical research at NYU Langone Health's Perlmutter Cancer Center.
Yale Cancer Center researchers were awarded a $2.8 million grant from NCI to evaluate and model cytokine signaling related to immunotherapy for cancer.
Thermo Fisher Scientific and Chugai Pharmaceutical Co. Ltd., have signed a companion diagnostic agreement and applied to the Ministry of Health, Labour and Welfare to expand the use of the Oncomine Dx Target Test in Japan.
By making lung cancer screening available to a larger population, the new guideline from the U.S. Preventive Services Task Force could save an additional 120 lives per 100,000 Americans, said Michael J. Barry, a member of the Task Force, and a professor of medicine at Harvard Medical School.
The U.S. Preventive Services Task Force has recommended expanding the eligible age range and broadening the risk threshold for annual low-dose CT screening for lung cancer.
